California Public Employees Retirement System
APLS

California Public Employees Retirement System’s Apellis Pharmaceuticals APLS Stock Holding History

California Public Employees Retirement System’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-186,328
Closed -$4.68M – 1064
2025
Q4 		$4.68M Buy
186,328
+40,140
+27% +$942K ﹤0.01% 1049
2025
Q3 		$3.31M Buy
146,188
+11,551
+9% +$269K ﹤0.01% 1070
2025
Q2 		$2.33M Buy
134,637
+7,931
+6% +$147K ﹤0.01% 1095
2025
Q1 		$2.77M Buy
126,706
+47
+0% +$1.3K ﹤0.01% 1095
2024
Q4 		$4.04M Sell
126,659
-10,935
-8% -$329K ﹤0.01% 1091
2024
Q3 		$3.97M Sell
137,594
-35,980
-21% -$1.33M ﹤0.01% 1105
2024
Q2 		$6.66M Buy
173,574
+27,741
+19% +$1.26M ﹤0.01% 988
2024
Q1 		$8.57M Hold
145,833
– – 0.01% 945
2023
Q4 		$8.73M Sell
145,833
-38,011
-21% -$1.93M 0.01% 922
2023
Q3 		$6.99M Buy
183,844
+1,656
+0.9% +$72.7K 0.01% 976
2023
Q2 		$16.6M Buy
182,188
+40,182
+28% +$3.47M 0.01% 667
2023
Q1 		$9.37M Sell
142,006
-49,958
-26% -$2.88M 0.01% 880
2022
Q4 		$9.93M Buy
191,964
+22,282
+13% +$1.18M 0.01% 906
2022
Q3 		$11.6M Buy
+169,682
New +$10M 0.01% 798
2021
Q2 		– Sell
-122,358
Closed -$5.25M – 1627
2021
Q1 		$5.25M Sell
122,358
-17,620
-13% -$834K ﹤0.01% 1398
2020
Q4 		$8.01M Buy
139,978
+3,644
+3% +$154K 0.01% 1153
2020
Q3 		$4.11M Buy
136,334
+3,500
+3% +$105K ﹤0.01% 1369
2020
Q2 		$4.34M Buy
132,834
+5,622
+4% +$181K ﹤0.01% 1281
2020
Q1 		$3.41M Buy
127,212
+17,313
+16% +$615K ﹤0.01% 1262
2019
Q4 		$3.37M Buy
109,899
+20,354
+23% +$563K ﹤0.01% 1722
2019
Q3 		$2.16M Buy
89,545
+45,670
+104% +$1.26M ﹤0.01% 1839
2019
Q2 		$1.11M Buy
43,875
+6,738
+18% +$137K ﹤0.01% 2095
2019
Q1 		$724K Hold
37,137
– – ﹤0.01% 2402
2018
Q4 		$490K Sell
37,137
-1,500
-4% -$23K ﹤0.01% 2556
2018
Q3 		$687K Sell
38,637
-8,279
-18% -$153K ﹤0.01% 2529
2018
Q2 		$1.03M Buy
+46,916
New +$1.08M ﹤0.01% 2312

Other funds holding APLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

California Public Employees Retirement System's APLS Position: Q1 2026 in Review

California Public Employees Retirement System sold out of Apellis Pharmaceuticals (APLS) in Q1 2026, closing a stake of 186,328 shares — an estimated $4.68M sold.

California Public Employees Retirement System first reported a position in APLS in Q2 2018 and held it in 26 quarters. The position peaked at $16.6M in Q2 2023. 324 funds tracked by Wall St. Rank hold APLS as of Q1 2026.

  • California Public Employees Retirement System reported no remaining Apellis Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • California Public Employees Retirement System sold 186,328 Apellis Pharmaceuticals shares in Q1 2026, an estimated $4.68M.
  • California Public Employees Retirement System first reported a position in Apellis Pharmaceuticals in Q2 2018 and held it in 26 quarters.
  • California Public Employees Retirement System's Apellis Pharmaceuticals position peaked at $16.6M in Q2 2023.
  • 324 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q1 2026.

Based on California Public Employees Retirement System's 13F filing for Q1 2026, filed 6 May 2026.